CannabisNewsBreaks Archive - Page 419 of 428

MondayJul 17, 2017 2:10 pm

CannabisNewsBreaks – SinglePoint (SING) Serves Legal Cannabis Market with Bitcoin Payment Solution; Invests in Equipment, Consulting Space

SinglePoint, Inc. (OTC: SING) is serving up prime opportunities for investors as it expands its array of offerings for the legal cannabis market—all without ever touching the marijuana plant. Many savvy investors are jumping aboard the cannabis bandwagon, and SinglePoint is involved in two of the most promising investment options currently available in that market: bitcoin digital currency as a solution for currently “unbankable” marijuana businesses and hydroponics products and consulting for marijuana growers. “More and more investment opportunities are arising in the legal cannabis industry, and SinglePoint is poised to be a major player. Through its subsidiary, SingleSeed (www.SingleSeed.com),…

FridayJul 14, 2017 12:11 pm

CannabisNewsBreaks – MassRoots, Inc. (MSRT) Shares Fall on Close of Odava Acquisition

Shares of MassRoots (OTCQB: MSRT) dipped 9% after the company this morning said it has closed the previously announced acquisition of Odava, Inc. in exchange for cash and common stock consideration. Following the acquisition, the company is now able to offer dispensaries a complete suite of software to manage their regulatory compliance, restructure their supply chain, and develop consumer loyalty programs. "The Odava acquisition diversifies our revenue streams while also enabling the platform integrations necessary to effectively monetize MassRoots' audience," MassRoots chief executive officer Isaac Dietrich stated in the news release. To view the full press release, visit: http://nnw.fm/u2GMT About MassRoots…

FridayJul 14, 2017 9:23 am

CannabisNewsBreaks – India Globalization Capital, Inc. (NYSE: IGC) Reports Financial Results for Fiscal Year Ended March 31, 2017

India Globalization Capital, Inc. (NYSE MKT: IGC), a developer of cannabis-based therapies to treat a variety of life-altering conditions, this morning announced its financial results for the fiscal year ended March 31, 2017. “In fiscal 2017, our major accomplishments include the advancement of our phytocannabinoid patent filing portfolio to large market indications,” Ram Mukunda, CEO of IGC, noted in the news release. “And in order to keep this focus on the medical cannabis industry, we disposed of our low-margin iron ore and electronic trading businesses, and retired about 10% of our outstanding common stock; thus reducing revenue, PP&E, and stockholder’s…

WednesdayJul 12, 2017 12:06 pm

CannabisNewsBreaks – ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) Lists Common Shares on OTCQB Venture Market and Frankfurt Stock Exchange

ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) this morning announced that its common shares have been approved for trading on the OTCQB Venture Market, under the symbol ‘ABCCF’, and on the Frankfurt Stock Exchange, under the symbol ‘23Q’. The company’s common shares will also continue to trade on the TSX Venture Exchange under the symbol ‘ABCN’. The company expects that these listings will provide a number of long-term benefits, including greater visibility and convenience for investors in the United States and Europe. As a result of this expanded base of potential shareholders, ABcann will likely benefit from enhanced liquidity moving…

MondayJul 10, 2017 10:09 am

CannabisNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Enters Definitive Agreement for $15 Million Investment

ABcann Global Corporation (TSXV: ABCN) this morning announced the signing of a definitive subscription agreement with Cannabis Wheaton Income Corp. (TSXV: CBW). Under the terms of the deal, Cannabis Wheaton has agreed to purchase $15 million of ABcann common shares at an agreed-upon valuation of $2.25 per share. Completion of this first subscription, which forms part of a larger phased investment by Cannabis Wheaton, is expected to occur by July 31, 2017, subject to customary closing conditions. “We are pleased to move forward with the initial funding phase of our partnership with Cannabis Wheaton and to welcome them as new…

MondayJul 10, 2017 9:11 am

CannabisNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Enters Research and Development Collaboration with ATERA SAS

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into a research and development collaboration with ATERA SAS of France, a leading tissue engineering company specializing in the development of advanced human tissue models. Under the terms of the agreement, ATERA will develop 3D human skin models of Epidermolysis Bullosa (EB) to be used in the evaluation of INM-750, InMed’s proprietary topical cannabinoid product candidate targeted as a therapy in EB and other potential dermatological and wound-healing applications. “INM-750 has demonstrated significant potential in pre-clinical models to address symptomatic improvement of EB including…

ThursdayJul 06, 2017 12:47 pm

CannabisNewsBreaks – MassRoots, Inc. (MSRT) Shares Rise on Acquisition of Odava Compliance Platform

MassRoots (OTCQB: MSRT) shares are up 8% mid-day on news that the company has entered a definitive agreement to acquire Odava, Inc. for cash and shares of MassRoots’ common stock. Odava is a platform technology company that delivers compliance, point-of-sale, and supply chain management to streamline business operations for the cannabis industry. "We expect with MassRoots' resources and relationships, we can grow the number of dispensaries utilizing Odava from dozens to hundreds by early next year. In the near future, we believe a significant percentage of all transactions occurring in the regulated cannabis industry will occur on our platform," MassRoots…

ThursdayJul 06, 2017 10:21 am

CannabisNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Included in the Horizons Medical Marijuana Life Sciences ETF

ABcann Global Corporation (TSXV: ABCN) yesterday announced its inclusion in the Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ). The ETF is a first-of-its-kind index offering investors direct exposure to a basket of North American life sciences companies with significant business activities in the medical marijuana sector. “The Horizons ETF represents a new type of investment, a fund that tracks an industry in which there is considerable interest but which had no prior investment vehicle through which investors could gain broad exposure,” Aaron Keay, CEO of ABcann, stated in the news release. “Our inclusion in the ETF represents an important…

FridayJun 30, 2017 2:12 pm

CannabisNewsBreaks – Player’s Network, Inc. (PNTV) Announces Availability of Green Leaf Farms Rosin Products at Las Vegas Dispensary

Player’s Network, Inc. (OTCQB: PNTV) today announced the availability of its Green Leaf Farms rosin products at the Pisos Dispensary, located just a few miles from the Las Vegas Strip. “This day has been a long time coming. It marks both the end of prohibition and the true beginning of mass distribution for Green Leaf Farms products,” Mark Bradley, CEO of Player’s Network, stated in the news release. “Our products are now available at the Pisos Dispensary in Las Vegas, as well as in top notch dispensaries in Henderson. We are aggressively moving on the opportunities provided by this growing…

FridayJun 30, 2017 11:46 am

CannabisNewsBreaks – ABcann Global Corporation (TSXV: ABCN) Announces Appointment of Dr. Michael Shannon as Chief Medical Consultant

On Thursday, ABcann Global Corporation (TSXV: ABCN) announced that it has retained the services of Dr. Michael Shannon as its chief medical consultant. Shannon brings decades of health care experience to the ABcann team, including time in both the private and public sectors. Among Shannon’s career highlights, in 1996, he assumed responsibilities within Health Canada for re-organizing the Canadian blood system and the development of a new corporate entity dedicated exclusively to the management of blood services in Canada. In 2000, he entered the private sector, simultaneously directing a phase III clinical trial in Canada, the United States and Great…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks